Literature DB >> 498050

Estradiol and testosterone levels in the peripheral and ovarian circulations in patients with endometrial cancer.

J G Schenker, D Weinstein, E Okon.   

Abstract

Estradiol and testosterone levels in the peripheral and ovarian circulation of patients with endometrial cancer and of postmenopausal women were studied. These levels proved to be the same in the two groups. The ovaries of neither group secreted estradiol. The testosterone level in the ovarian circulation of all examined women was four times higher than that in the peripheral circulation, thus indicating the ovarian origin of testosterone.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 498050     DOI： 10.1002/1097-0142(197911)44:5<1809::aid-cncr2820440540>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  4 in total

Review 1.  Pelvic radiotherapy, sex hormones, and breast cancer.

Authors:  P D Inskip
Journal:  Cancer Causes Control       Date:  1994-09       Impact factor: 2.506

2.  Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies.

Authors:  K Watanabe; H Sasano; N Harada; M Ozaki; H Niikura; S Sato; A Yajima
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

3.  Kaempferol, a natural dietary flavonoid, suppresses 17β-estradiol-induced survivin expression and causes apoptotic cell death in endometrial cancer.

Authors:  Agapiti Hipoliti Chuwa; Kenbun Sone; Katsutoshi Oda; Michihiro Tanikawa; Asako Kukita; Machiko Kojima; Shinya Oki; Tomohiko Fukuda; Makoto Takeuchi; Aki Miyasaka; Tomoko Kashiyama; Yuji Ikeda; Kazunori Nagasaka; Mayuyo Mori-Uchino; Yoko Matsumoto; Osamu Wada-Hiraike; Hiroyuki Kuramoto; Kei Kawana; Yutaka Osuga; Tomoyuki Fujii
Journal:  Oncol Lett       Date:  2018-08-21       Impact factor: 2.967

4.  Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients.

Authors:  G Secreto; C Recchione; A Cavalleri; M Miraglia; V Dati
Journal:  Br J Cancer       Date:  1983-02       Impact factor: 7.640
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.